Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-572-7 | CAS number: 142-92-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No data are available for the reproductive toxicity endpoint. A waiver is proposed for the 2-generation reproductive toxicity study, in line with Column 2 of Annex IX of the REACH Regulation and consistent with current guidance. The 2-generation study is triggered at this tonnage band by alerts or concerns for reproductive toxicity from available data, QSAR or from related substances. The key repeated dose toxicity study for hexyl acetate was a read-across 90-day inhalation study performed with the structurally related substance butyl acetate. This study included assessment of testes weight, histopathology and sperm counts. No clear effects of treatment were apparent on these parameters. There is therefore no specific alert or concern over the reproductive toxicity of hexyl acetate.
Short description of key information:
No data are available for the reproductive toxicity endpoint.
Effects on developmental toxicity
Description of key information
Studies using gavage administration in the rat are available for octyl acetate and n-hexanol. Studies using inhalation exposure in the rat are available for n-butyl acetate and hexanol
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 200 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Studies using gavage administration in the rat are available for octyl acetate and n-hexanol. Both studies indicate possible mild developmental toxicity at the limit dose of 1000 mg/kg bw/d, however the resulting NOAEL is lower for the n-hexanol study as a consequence of dose spacing
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 3 800 mg/m³
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- Studies using inhalation exposure in the rat are available for n-butyl acetate and hexanol..
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
A weight of evidence approach is used for developmental toxicity, using studies in the rat performed with a number of read-across substances using oral (gavage) dosing and inhalation exposure.
A gavage study performed with octyl acetate (Daughtrey et al, 1989) reported maternal toxicity at dose levels of 500 and 1000 mg/kg bw/d; toxicity at the highest dose level included maternal mortality. Developmental toxicity in this study was limited to a possible slight increase in the incidence of vertebral variations/malformations at the highest dose level only.
A gavage study performed with n-hexanol (Rodwell et al, 1988) reports maternal toxicity (clinical signs and reduced weight gain) and a slight reduction in foetal weight at the highest dose level of 1000 mg/kg bw/d. No effects were seen at the next dose level of 200 mg/kg bw/d.
An inhalation study performed using n-butyl acetate (Saillenfait et al, 2007) reported maternal toxicity (reduced weight gain and/or food consumption at exposure levels of 1000, 2000 and 3000 ppm); developmental toxicity was limited to reduced foetal weight at the highest concentration.
An inhalation study performed using hexanol (Nelson et al, 1989; 1990) showed no maternal toxicity at an exposure level of 3800 mg/m3. A slight increase in resorption rate seen at this exposure level was within the control range.
The results of developmental toxicity studies with read-across substances (analogues, metabolites) indicate possible mild developmental toxicity only at very high and maternally toxic dose levels. There is no evidence for selective developmental toxicity.
Justification for selection of Effect on developmental toxicity: via oral route:
A weight of evidence approach is followed for this endpoint.
Justification for selection of Effect on developmental toxicity: via inhalation route:
Studies using inhalation exposure in the rat are available for n-butyl acetate and hexanol. The lower endpoint is from the hexanol study
Justification for classification or non-classification
There is no evidence for reproductive toxicity or for specific developmental toxicity in studies performed with read-across substances; developmental toxicity was mild and seen only at very high and maternally toxic dose levels. No classification for reproductive toxicity is therefore proposed according to the CLP Regulation.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1